Abstract
Analysis of the short term effects of the change in the reimbursement system for pharmaceutical products on 1 November, 1980, has shown that prices do have an influence on the demand for drugs. The active part of the insured population (PUG) is more responsive than the non-active (WIG). The low income WIG100S responded to the price increase, the higher income WIG75s did not. Because both the price and quantity variables derived from the NHI data are of dubious quality, one should be cautious in using the estimated elasticities for predictive purposes.
| Original language | English |
|---|---|
| Pages (from-to) | 69-81 |
| Number of pages | 13 |
| Journal | Acta Hospitalia |
| Volume | NO. 3 |
| Publication status | Published - 1984 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'The effects of cost sharing on the demand for prescription drugs in Belgium'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver